Chemotherapeutic drugs—more really is not better
- 1 May 2000
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 6 (5), 500-502
- https://doi.org/10.1038/74969
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicityJCI Insight, 2000
- Angiogenic zip codeNature Biotechnology, 1999
- Angiogenesis and Growth of Murine Colon Carcinoma are Dependent on Infiltrating LeukocytesCancer Biotherapy & Radiopharmaceuticals, 1999
- Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawalProceedings of the National Academy of Sciences of the United States of America, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Modulation of the Organ Microenvironment for Treatment of Cancer MetastasisJNCI Journal of the National Cancer Institute, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Metastasis Results from Preexisting Variant Cells Within a Malignant TumorScience, 1977
- Transplacental Carcinogenesis by StilbestrolNew England Journal of Medicine, 1971
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889